IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
caspofungin
caspofungin
Restricted Medications
Non-Formulary
Brand names:
Cancidas
Form
Strength
POWDER FOR INJECTION, INTRAVENOUS
50 mg; 70 mg
Display
Echinocandins
Class:
081416
Medication comments:
Per policy, these drugs are subject to renal dosing adjustments by pharmacy.
Renal Dosing Program
View all
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
caspofungin
IV
(
Cancidas
©
)
70 mg x1 then
50 mg/day
No adjustment necessary
Per policy, orders for these non-formulary agents will be changed to formulary equivalents.
View all
Non-Formulary Agent
Formulary Equivalent
caspofungin (Cancidas)
anidulafungin (Eraxis)
Last updated:
May. 24, 2021
Renal Adjustment Policy
caspofungin subject to adjustments by pharmacy.
Therapeutic Interchange Policy
anidulafungin (Eraxis)
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
• Indications
Comments
(Cancidas©)
50 mg/day